Project Grant HT94252410236
Award Date 9/1/24
Completion Date 8/31/28
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Kansas City, MO 64128, USA
Similar Awards
- Yale University received a $1,618,571 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The award will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
- Yale University received a $1,731,409 project grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
- This $1,552,348 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research by the Children's Mercy Hospital in Kansas City, Missouri to investigate the role of the SH3BP2 protein in the immunopathogenesis of nephrotic syndrome. The award period runs from September 1, 2024 to August 31, 2028. As a recipient of numerous federal grants and contracts, Children's Mercy Hospital conducts cutting-edge...
- The Defense Health Agency awarded $1,029,002 through the Military Medical Research and Development program (CFDA 12.420) to the Arizona Veterans Research and Education Foundation for a three-year project grant spanning September 1, 2025, through August 31, 2028. The project, "Identification of Recessive Prostate Cancer Risk Alleles in the Million Veterans Program," represents a biomedical research initiative aimed at advancing cancer research relevant to military service members and...
- The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
- This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $2,531,888 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to study "CORRECTING CYTOSKELETAL ABNORMALITIES AND PODOCYTE VULNERABILITY IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS." The 4-year award, starting on May 1, 2024, supports Bidmc's research aimed at improving treatments for this kidney disorder. As a leading academic medical center, Bidmc has an...
- This federal Project Grant award of $1,383,874.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of Maryland, Baltimore to decipher the intramolecular regulatory mechanism of polycystin 1, which is implicated in polycystic kidney disease. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the scientific understanding of this...
- This $299,998 Project Grant award was provided by the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the University of Nebraska Medical Center (UNMC). The award will support a 2-year research project from July 2024 to July 2026 entitled "VAP-1 AND METHYLGLYOXAL AS NOVEL TARGETS IN LUPUS NEPHRITIS". Through this funding, UNMC will conduct innovative biomedical research to investigate new treatment approaches for lupus nephritis, a...
- Federal Grant Award Summary 149 Bio LLC received a $5.1M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2029. The award supports the development of a myeloid-targeted novel therapeutic intervention for glomerular diseases. This research initiative will be conducted at the awardee's facility in Miami, FL and aims to advance biomedical solutions relevant to military health...
- The Department of the Army Medical Command awarded a $2,455,660 project grant to Beth Israel Deaconess Medical Center, Inc. (doing business as Bidmc) to support research on "TRANSCRIPTION FACTORS AS THERAPEUTIC TARGETS IN FOCAL SEGMENTAL GLOMERULAR SCLEROSIS." The period of performance for this award is from September 30, 2022 through September 29, 2026. The grant is being funded through the Military Medical Research and Development program (CFDA 12.420). This program aims to transform...